Myeloma clonotypic B cells are hampered in their ability to undergo B-cell differentiation in vitro

British Journal of Haematology

Volumn 119, Issue 1, 2002, Pages 54-61

  Guikema, Jeroen E J ^a,b   Vellenga, Edo ^b   Bakkus, Marleen H C ^c   Bos, Nicolaas A ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

CD40; Clonotypic B cell; Differentiation; Multiple myeloma

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; B-LYMPHOCYTES; BLOTTING, SOUTHERN; CD40 LIGAND; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; HUMANS; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-4; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036398413     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03789.x     Document Type: Article

References (37)

1. Agematsu, K., Nagumo, H., Oguchi, Y., Nakazawa, T., Fukushima, K., Yasui, K., Ito, S., Kobata, T., Morimoto, C. & Komiyama, A. (1998) Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood, 91, 173-180.
2. Andersen, N.S., Larsen, J.K., Christiansen, J., Pedersen, L.B., Christophersen, N.S., Geisler, C.H. & Jurlander, J. (2000) Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood, 96, 2219-2225.
3. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
4. Bakkus, M.H.C., Heirman, C., VanRiet, I., VanCamp, B. & Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2335.
5. Bakkus, M.H.C., VanRiet, I., VanCamp, B. & Thielemans, K. (1994) Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. British Journal of Haematology, 87, 68-74.
6. Bakkus, M.H.C., VanRiet, I., Degreef, C., VanCamp, B. & Thielemans, K. (1995) The clonogenic precursor cell in multiple myeloma. Leukemia and Lymphoma, 18, 221-229.
7. Bakkus, M.H., Schots, R., La, P.B., Van Riet, I., Thielemans, K., De Waele, M. & Van Camp, B. (2000) Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient. European Journal of Haematology, 65, 348-355.
8. Berard, M., Casamayor-Palleja, M., Billian, G., Bella, C., Mondiere, P. & Defrance, T. (1999) Activation sensitizes human memory B cells to B-cell receptor-induced apoptosis. Immunology, 98, 47-54.
9. Bergsagel, P.L., Smith, A.M., Szczepek, A., Mant, M.J., Belch, A.R. & Pilarski, L.M. (1995) In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood, 85, 436-447.
10. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M.M. & Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
11. Billadeau, D., Ahmann, G., Greipp, P. & Van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. Journal of Experimental Medicine, 178, 1023-1031.
12. Billadeau, D., Van Ness, B., Kimlinger, T., Kyle, R.A., Therneau, T.M., Greipp, P.R. & Witzig, T.E. (1996) Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood, 88, 289-296.
13. Chen, B.J. & Epstein, J. (1996) Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood, 87, 1972-1976.
14. Choe, J. & Choi, Y.S. (1998) IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. European Journal of Immunology, 28, 508-515.
15. Corradini, P., Boccadoro, M., Voena, C. & Pileri, A. (1993) Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in IgG and IgA secreting multiple myelomas. Journal of Experimental Medicine, 178, 1091-1096.
16. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
17. Gu, Z.J., Costes, V., Lu, Z.Y., Zhang, X.G., Pitard, V., Moreau, J.F., Bataille, R., Wijdenes, J., Rossi, J.F. & Klein, B. (1996) Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood, 88, 3972-3986.
18. Guikema, J.E., Vellenga, E., Veeneman, J.M., Hovenga, S., Bakkus, M.H., Klip, H. & Bos, N.A. (1999) Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. British Journal of Haematology, 104, 748-754.
19. Harousseau, J.L., Attal, M., Divine, M., Marit, G., Leblond, V., Stoppa, A.M., Bourhis, J.H., Caillot, D., Boasson, M. & Abgrall, J.F. (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma. Blood, 85, 3077-3085.
20. Itoh, K. & Hirohata, S. (1995) The role of IL-10 in human B cell activation, proliferation, and differentiation. Journal of Immunology, 154, 4341-4350.
21. Lu, Z.Y., Zhang, X.G., Rodriguez, C., Wijdenes, J., Gu, Z.J., Morel-Fournier, B., Harousseau, J.L., Bataille, R., Rossi, J.F. & Klein, B. (1995) Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood, 85, 2521-2527.
22. Malgeri, U., Baldini, L., Perfetti, V., Fabris, S., Vignarelli, M.C., Colombo, G., Lotti, V., Compasso, S., Bogni, S., Lombardi, L., Maiolo, A.T. & Neri, A. (2000) Detection of t(4;14) (p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts. Cancer Research, 60, 4058-4061.
23. Morimoto, S., Kanno, Y., Tanaka, Y., Tokano, Y., Hashimoto, H., Jacquot, S., Morimoto, C., Schlossman, S.F., Yagita, H., Okumura, K. & Kobata, T. (2000) CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. Journal of Immunology, 164, 4097-4104.
24. Pilarski, L.M. & Belch, A.R. (1994) Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood, 83, 724-736.
25. Pilarski, L.M., Masellis-Smith, A., Szczepek, A., Mant, M.J. & Belch, A.R. (1996) Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma. Leukemia and Lymphoma, 22, 375-383.
26. Pilarski, L.M., Szczepek, A.J. & Belch, A.R. (1997) Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma. Blood, 90, 3751-3759.
27. Pilarski, L.M., Hipperson, G., Seeberger, K., Pruski, E., Coupland, R.W. & Belch, A.R. (2000) Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood, 95, 1056-1065.
28. Randall, T.D., Heath, A.W., Santos-Argumedo, L., Howard, M.C., Weissman, I.L. & Lund, F.E. (1998) Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity, 8, 733-742.
29. Sahota, S.S., Leo, R., Hamblin, T.J. & Stevenson, F.K. (1997) Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood, 89, 219-226.
30. Strijbosch, L.W., Does, R.J. & Buurman, W.A. (1988) Computer aided design and evaluation of limiting and serial dilution experiments. International Journal of Biomedical Computing, 23, 279-290.
31. Szczepek, A.J., Bergsagel, P.L., Axelsson, L., Brown, C.B., Belch, A.R. & Pilarski, L.M. (1997) CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood, 89, 1824-1833.
32. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. & Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood, 92, 2844-2855.
33. Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. Journal of Immunology, 126, 1614-1619.
34. Tomlinson, I.M., Walter, G., Marks, J.D., Llewelyn, M.B. & Winter, G. (1992) The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. Journal of Molecular Biology, 227, 776-798.
35. Vescio, R., Cao, J., Hong, C., Lee, J., Wu, C., Der, D.M., Wu, V., Newman, R., Lichtenstein, A. & Berenson, J. (1995) Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. Journal of Immunology, 155, 2487-2497.
36. Visser, H.P., Tewis, M., Willemze, R. & Kluin-Nelemans, J.C. (2000) Mantle cell lymphoma proliferates upon IL-10 in the CD40 system. Leukemia, 14, 1483-1489.
37. Willems, P., Verhagen, O., Segeren, C., Veenhuizen, P., Guikema, J., Wiemer, E., Groothuis, L., Jong, T.B., Kok, H., Bloem, A., Bos, N., Vellenga, E., Mensink, E., Sonneveld, P., Lokhorst, H., van der Schoot, E. & Raymakers, R. (2000) Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group. Blood, 96, 63-70.